Caseware UK (AP4) 2023.0.135 2023.0.135 2024-05-312023-05-222024-05-31No description of principal activityfalse2023-05-24false1The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 14890845 2023-05-23 14890845 2023-05-24 2024-05-31 14890845 2022-05-24 2023-05-23 14890845 2024-05-31 14890845 c:Director1 2023-05-24 2024-05-31 14890845 c:Director1 2024-05-31 14890845 c:RegisteredOffice 2023-05-24 2024-05-31 14890845 d:CurrentFinancialInstruments 2024-05-31 14890845 c:Micro-entities 2023-05-24 2024-05-31 14890845 c:AuditExempt-NoAccountantsReport 2023-05-24 2024-05-31 14890845 c:FullAccounts 2023-05-24 2024-05-31 14890845 c:PrivateLimitedCompanyLtd 2023-05-24 2024-05-31 iso4217:GBP xbrli:pure

Registered number: 14890845









EXPANDBIO LIMITED







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE PERIOD ENDED 31 MAY 2024

 
EXPANDBIO LIMITED
 
 
COMPANY INFORMATION


Director
S Karagiannoglou (appointed 22 May 2023)




Registered number
14890845



Registered office
18a/20 King Street
Maidenhead

Berkshire

United Kingdom

SL6 1EF




Accountants
Donald Reid Limited
Chartered Accountants

18a/20 King Street

Maidenhead

Berkshire

SL6 1DT





 
EXPANDBIO LIMITED
 

CONTENTS



Page
Balance sheet
1


 
EXPANDBIO LIMITED
REGISTERED NUMBER: 14890845

BALANCE SHEET
AS AT 31 MAY 2024

2024
£


Current assets
1,480

Creditors: amounts falling due within one year
(2,900)

Net current (liabilities)/assets
 
 
(1,420)

Total assets less current liabilities
(1,420)


Net (liabilities)/assets
(1,420)



Capital and reserves
(1,420)


Notes


General information

ExpandBio Limited is a private company limited by shares. The company was incorporated in the United Kingdom and is registered in England and Wales. The registration number 14890845. The registered office is Prince Albert House, 18a/20 King Street, Maidenhead, Berkshire, United Kingdom, SL6 1EF. 


Average number of employees

The average monthly number of employees, including directors, during the period was 1.

The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the period in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared in accordance with the provisions applicable to entities subject to the micro-entities' regime.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 8 August 2024.




S Karagiannoglou
Director

 
Page 1